Prompt intervention for severe aortic stenosis patients demonstrates lower healthcare costs, improved clinical outcomes – Edwards Lifesciences
Edwards Lifesciences announced new economic and clinical evidence on severe aortic stenosis (AS) presented as a late-breaking clinical trial at EuroPCR 2025, further contributing to the extensive body… read more.

